Differential expression of CD44 in canine melanocytic tumours

Journal of Comparative Pathology

Volumn 130, Issue 2-3, 2004, Pages 171-180

  Serra, M ^a   Rabanal, R M ^a   Miguel, L ^a   Domenzain, C ^a   Bassols, A ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

CD44; Dog; Hyaluronan; Melanoma; Tumuor; Versican

Indexed keywords

CELL SURFACE RECEPTOR; HERMES ANTIGEN; HYALURONIC ACID; PROTEOGLYCAN; VERSICAN;

ANIMAL CELL; ANIMAL DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN FUNCTION; ARTICLE; ASSAY; CANCER CELL CULTURE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOG; EXTRACELLULAR MATRIX; GENE OVEREXPRESSION; JUVENILE MELANOMA; MELANOMA; MOLECULAR INTERACTION; NONHUMAN; STATISTICAL ANALYSIS; TUMOR BIOPSY;

CANIS FAMILIARIS;

EID: 1442326809     PISSN: 00219975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcpa.2003.10.006     Document Type: Article

References (30)

1. Ahrens, T., Sleeman, J. P., Schempp, C. M., Howells, N., Hofmann, M., Ponta, H., Herrlich, P. and Simon, J. C. (2001). Soluble CD44 inhibits melanoma tumor growth by blocking cell surface CD44 binding to hyaluronic acid. Oncogene, 20, 3399-3408.
2. Alldinger, S., Baumgartner, W., Kremmer, E. and Fonfara, S. (1999). Characterization of a canine CD44 specific monoclonal antibody. Journal of Veterinary Medicine A, 46, 19-32.
3. Bajorath, J. (2000). Molecular organization, structural features, and ligand binding characteristics of CD44, a highly variable cell surface glycoprotein with multiple functions. Proteins, 39, 103-111.
4. Bartolazzi, A., Peach, R., Aruffo, A. and Stamenkovic, I. (1994). Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development. Journal of Experimental Medicine, 180, 53-66.
5. Birch, M., Mitchell, S. and Hart, I. R. (1991). Isolation and characterization of human melanoma cell variants expressing high and low levels of CD44. Cancer Research, 51, 6660-6667.
6. Dietrich, A., Tanczos, E., Vanscheidt, W., Schopf, E. and Simon, J. C. (1997). High CD44 surface expression on primary tumours of malignant melanoma correlates with increased metastatic risk and reduced survival. European Journal of Cancer, 33, 926-930.
7. East, J. A., Mitchell, S. D. and Hart, I. R. (1993). Expression and function of the CD44 glycoprotein in melanoma cell lines. Melanoma Research, 3, 341-346.
8. Evanko, S. P., Johnson, P. Y., Braun, K. R., Underhill, C. B., Dudhia, J. and Wight, T. N. (2001). Platelet-derived growth factor stimulates the formation of versican-hyaluronan aggregates and pericellular matrix expansion in arterial smooth muscle cells. Archives of Biochemistry and Biophysics, 394, 29-38.
9. Faassen, A. E., Schrager, J. A., Klein, D.J., Oegema, T. R., Couchman, J. R. and McCarthy, J. B. (1992). A cell surface chondroitin sulfate proteoglycan, immunologically related to CD44, is involved in type I collagen-mediated melanoma cell motility and invasion. Journal of Cell Biology, 116, 521-531.
10. Goebeler, M., Kaufmann, D., Brocker, E. B. and Klein, C. E. (1996). Migration of highly aggressive melanoma cells on hyaluronic acid is associated with functional changes, increased turnover and shedding of CD44 receptors. Journal of Cell Science, 109, 1957-1964.
11. Goodison, S., Urquidi, V. and Tarin, D. (1999). CD44 cell adhesion molecules. Molecular Pathology, 52, 189-196.
12. Guo, Y., Ma, J., Wang, J., Che, X., Narula, J., Bigby, M., Wu, M. and Sy, M. S. (1994). Inhibition of human melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibody. Cancer Research, 54, 1561-1565.
13. Harwood, C. A., Greenm, M. A. and Cook, M. G. (1996). CD44 expression in melanocytic lesions: a marker of malignant progression? British Journal of Dermatology, 135, 876-882.
14. Karjalainen, J. M., Tammi, R. H., Tammi, M. I., Eskelinen, M. J., Agren, U. M., Parkkinen, J. J., Alhava, E. M. and Kosma, V. M. (2000). Reduced level of CD44 and hyaluronan associated with unfavorable prognosis in clinical stage I cutaneous melanoma. American Journal of Pathology, 157, 957-965.
15. Knutson, J. R., Iida, J., Fields, G. B. and McCarthy, J. B. (1996). CD44/chondroitin sulfate proteoglycan and alpha 2 beta 1 integrin mediate human melanoma cell migration on type IV collagen and invasion of basement membranes. Molecular Biology of the Cell, 7, 383-396.
16. Manten-Horst, E., Danen, E. H., Smit, L., Snock, M., Le Poole, I. C., Van Muijen, G. N., Pals, S. T. and Ruiter, D. J. (1995). Expression of CD44 splice variants in human cutaneous melanoma and melanoma cell lines is related to tumor progression and metastatic potential. International Journal of Cancer, 64, 182-188.
17. Peck, D. and Isacke, C. M. (1996). CD44 phosphorylation regulates melanoma cell and fibroblast migration on, but not attachment to, a hyaluronan substratum. Current Biology, 6, 884-890.
18. Schaider, H., Soyer, H. P., Heider, K. H., Hofmann-Wellenhof, R., Zatloukal, K., Smolle, J. and Kerl, H. (1998). CD44 and variants in melanocytic skin neoplasms. Journal of Cutaneous Pathology, 25, 199-203.
19. Seelentag, W. K., Boni, R., Gunthert, U., Futo, E., Burg, G., Heitz, P. U. and Roth, J. (1997). Expression of CD44 isoforms and beta 1,6-branched oligosaccharides in human malignant melanoma is correlated with tumor progression but not with metastatic potential. Journal of Cutaneous Pathology, 24, 206-211.
20. Serra, M., Pastor, J., Domenzain, C. and Bassols, A. (2002). Effect of transforming growth factor-beta1, insulin-like growth factor-1, and hepatocyte growth factor on proteoglycan production and regulation in canine melanoma cell lines. American Journal of Veterinary Research, 63, 1151-1158.
21. Smith, S. H., Goldschmidt, M. H. and McManus, P. M. (2002). A comparative review of melanocytic neoplasms. Veterinary Pathology, 39, 651-678.
22. Tammi, R., Tammi, M., Hakkinen, L. and Larjava, H. (1990). Histochemical localization of hyaluronate in human oral epithelium using a specific hyaluronate-binding probe. Archives of Oral Biology, 35, 219-224.
23. Thomas, L., Byers, H. R., Vink, J. and Stamenkovic, I. (1992). CD44H regulates tumor cell migration on hyaluronate-coated substrate. Journal of Cell Biology, 118, 971-977.
24. Thomas, L., Etoh, T., Stamenkovic, I., Mihm, M. C. Jr and Byers, H. R. (1993). Migration of human melanoma cells on hyaluronate is related to CD44 expression. Journal of Investigative Dermatology, 100, 115-120.
25. Touab, M., Villena, J., Barranco, C., Arumi-Uria, M. and Bassols, A. (2002). Versican is differentially expressed in human melanoma and may play a role in tumor development. American Journal of Pathology, 160, 549-557.
26. Turley, E. A., Noble, P. W. and Bourguignon, L. Y. (2002). Signaling properties of hyaluronan receptors. Journal of Biological Chemistry, 277, 4589-4592.
27. Underhill, C. B., Nguyen, H. A., Shizari, M. and Culty, M. (1993). CD44 positive macrophages take up hyaluronan during lung development. Developmental Biology, 155, 324-336.
28. Wolfe, L. G., Oliver, J. L. and Smith, B. B. (1987). Biologic characterization of canine melanoma cell lines. American Journal of Veterinary Research, 48, 1642-1648.
29. Yamaguchi, Y. (2000). Lecticans: organizers of the brain extracellular matrix. Cellular and Molecular Life Science, 57, 276-289.
30. Zimmermann, D. R. (2000). Versican. In: Proteoglycans: Structure, Biology and Molecular Interactions, R. V. Iozzo, Ed., Marcel Dekker, New York, pp. 327-341.